The Surgical Company – Connected Care

EARLY DETECTION OF PATIENT DETERIORATION

Sensium® is the only end-to-end system designed and optimised exclusively for ambulatory patients enabling early detection of deterioration of mobile patients in general medical and surgical wards. Sensium® is a discreet, wearable, wireless system for monitoring vital signs of patients outside of high acuity areas. By notifying clinicians of changes in patients’ vital signs, Sensium® brings the nurse to the deteriorating patient. 

Currently 75% of all adverse events and preventable deaths occur outside the ICU in unmonitored beds. Sensium® allows unmonitored beds to be easily and affordably converted to monitored beds to ensure that these adverse events and preventable patients deaths are minimised.

The system received FDA 510(k) clearance in 2011 and the CE Mark in 2013.

The key benefit of Sensium® is that it provides vital signs data between routine observation rounds which are typically conducted every four to eight hours. The system enables earlier detection of patient deterioration and allows nursing staff to intervene much more quickly – thereby improving patient care, shortening hospital stays and reducing healthcare costs.

The system is based on SENSIUM’s proprietary ultra-low power technologies. As a result, the Sensium® System is the only lightweight wearable system which has a six-day battery life and is capable of monitoring freely ambulatory patients.

SensiumVitals was developed over several years by world-renowned digital healthcare experts, including Professor Toumazou, Regius Professor of Engineering and founding director of the Institute of Biomedical Engineering at Imperial College.

Company’s Keywords:

vital signs monitoring, wireless medical devices, ultralow power wireless technologies